The Asenapine Transdermal System

Video

The first-and-only transdermal patch for adults with schizophrenia offers a new treatment.

Leslie Citrome, MD, MPH, talks about asenapine, or SECUDADO, the first-and-only transdermal patch formulation for the treatment of adults with schizophrenia approved by the U.S. Food and Drug Administration.

Read more about the asenapine transdermal system here. Alternatively, visit the product website here.

Dr Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College.

Related Videos
exciting, brain
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
© 2024 MJH Life Sciences

All rights reserved.